About Us

Overview

Brooks, Houghton & Company, Inc. ("BHC") is a merchant banking firm dedicated to providing investment banking services and direct investment to middle market private and public companies, and emerging-growth companies.

Formed in 1989, BHC emphasizes building long-term relationships with its clients by providing quality, innovative solutions to corporate finance needs, and recognizing the importance of relationships that are established through mutual trust and professional execution.

Applying these principles, BHC has earned an enviable reputation for providing discreet and high quality professional services to our clients, investors and referral sources.

BHC's merchant banking products and services include:

  • Debt and equity private placements - offered through Brooks Houghton Securities, Inc. ("BHS")
  • Mergers and acquisition advisory
  • Valuation and fairness opinions
  • General corporate finance advisory
  • Principal investments in interim and bridge capital, Lloyd's insurance syndicates, and long/short hedge funds

BHC has established alliances in key industries including media and entertainment, intellectual property, and healthcare.

Additionally, BHC is a member of Globalscope Partners, a premier global mergers and acquisitions advisors network.

Recent Firm News

  • BHC Serves as M&A Adviser to Generex Biotechnology Corporation on Final Tranche Acquisition - November 5, 2018

    Brooks, Houghton & Company, Inc. ("BHC") is pleased to announce that it advised Generex Biotechnology Corporation ("Generex") (OTCMKTS: GNBT) on the second and final tranche acquisition of remaining operating assets


  • BHC Serves as M&A Adviser to Generex Biotechnology Corporation on Acquisition of Assets - October 11, 2018

    Brooks, Houghton & Company, Inc. ("BHC") is pleased to announce that it advised Generex Biotechnology Corporation ("Generex") (OTCMKTS: GNBT) on the first tranche acquisition of certain operating assets from Veneto


  • Algaia Receives 4 Million Euro Boost - May 22, 2018

    Algaia, S.A., will accelerate development and install a new specialty seaweed extract production unit in its Lannilis (Brittany-France) manufacturing facility dedicated to specialty algae extracts.


Brooks, Houghton & Company, Inc.
780 Third Avenue • 35th Floor • New York, NY 10017 • Phone: (212) 753-1991 • Fax: (212) 753-7730 • info@brookshoughton.com
Securities offered through Brooks Houghton Securities , Inc.
Member FINRA and SIPC

Website Developed by: Smart Interactive Media